Anti-cancer Drug Discovery: Update and Comparisons in Yeast, Drosophila, and Zebrafish

Author(s): Guangxun Gao, Liang Chen, Chuanshu Huang

Journal Name: Current Molecular Pharmacology

Volume 7 , Issue 1 , 2014

Become EABM
Become Reviewer
Call for Editor


Discovery of novel cancer chemotherapeutics focuses on screening and identifying compounds that can target ‘cancer-specific’ biological processes while causing minimal toxicity to non-tumor cells. Alternatively, model organisms with highly conserved cancer-related cellular processes relative to human cells may offer new opportunities for anticancer drug discovery when combined with chemical screening. Some organisms used for chemotherapeutic discovery include yeast, Drosophila, and zebrafish which are similar in important ways relevant to cancer study but offer distinct advantages as well. Here, we describe these model attributes and the rationale for using them in cancer drug screening research.

Keywords: Anti-cancer drug discovery, Drosophila, HTS, model organism, yeast, zebrafish.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 02 July, 2014
Page: [44 - 51]
Pages: 8
DOI: 10.2174/1874467207666140702113629

Article Metrics

PDF: 68